According to a brokerage poll, the company’s global IT revenue is estimated at ₹22,445–24,397 crore in Q4, implying growth of -0.8 per cent to 3.6 per cent QoQ (cc) and -1.2 per cent to 0.4 per cent YoY (cc).
Wipro is set to announce its financial results for Q4FY26 on April 16. The company is expected to signal a muted start to FY27, with June-quarter IT services revenue guidance likely ranging from a 1.5 per cent decline to marginal 0.5 per cent growth sequentially in cc terms, as delays in deal ramp-ups weigh on performance.
According to a brokerage poll, the company’s global IT revenue is estimated at ₹22,445–24,397 crore in Q4, implying growth of -0.8 per cent to 3.6 per cent QoQ (cc) and -1.2 per cent to 0.4 per cent YoY (cc). Profit after tax (PAT) is projected at ₹3,569–3,791 crore, up 17.6 per cent -21.6 QoQ and 2.7 per cent –6.2 per cent YoY.
Brokerages expect Q1 revenue growth of -1.5 per cent to +0.5% QoQ (cc), weighed down by delayed deal ramp-ups, potential share losses, and pricing pressure. Overall revenue growth will include around 160 bps contribution from the DTS acquisition.
IT services EBIT margins are likely to contract by around 50 bps QoQ to around 16 per cent , due to DTS-related dilution, possible wage hikes, and slower growth momentum.
“Recurring IT Services EBIT margins are expected to dip 35bps qoq given wage hikes, effective March 1, 2026, large deal ramp up cost and full quarter consolidation of low margin business Harman DTS M&A, effective early December 2025, which will be partly compensated by tailwinds from currency and cost efficiencies,” observed an Equirus Capital report.
Similarly, a JM Financial Institutional Securities noted that headwinds include wage hikes and around 40 bps impact from acquisitions.
Deal TCV is expected to remain broadly in line with previous quarters, with a limited ramp-up in a few mega deals during Q4.
Order intake, especially large deals, is likely to stay healthy, supported by Wipro’s continued aggressive deal pursuit.
According to a MOFSL report, BFSI and healthcare are expected to remain stable, while consumer and EMR may stay under pressure due to tariff uncertainty and delayed decision-making. Slower ramp-up of some large deals is also weighing on growth.
Published on April 12, 2026
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。